2^nd International Conference on Genetic and Protein Engineering November 14-16, 2016 Atlanta, Georgia, USA

There are lot of applications used for protein but mainly we are having good research and number of companies and projects for the following applications Protein modification, targeting and degradation, Protein identification and validation, Protein profiling studies in diabetes, Imaging mass spectrometry and profiling of tissue sections, Designer proteins and Protein Dietary Supplements. This market is $56 billion in 2012 to $168 billion in 2017, a compound annual growth rate (CAGR) of 10.9% from 2012 through 2017. There are almost 3000 people from 60-65 universities in USA working for Genetic and Protein Engineering.

Cancer Genomics is the investigation of genetic changes in charge of disease, utilizing genome sequencing and bioinformatics. Cancer genomics is to enhance tumor treatment and results lies in figuring out which sets of qualities and quality communications influence diverse subsets of growths. Global Cancer Genome Consortium (ICGC) is a deliberate exploratory association that gives a discussion to joint effort among the world's driving growth and genomic specialists. The subjects like malignancy hereditary qualities, protein markers, Cancer Functional Genomics and Epigenomics, Bioinformatics and Systems Biology of Cancer and Big Data and Genome Medicine are secured in this taking after track.

Enzyme Engineering is the application genetic engineering techniques to enzyme technology. There are a number of properties which may be improved or altered by genetic engineering including the yield and kinetics of the enzyme, Structure of the enzymes, De novo design, Intersection of protein engineering and next-generation sequencing, Rational alteration of enzyme function, Combinatorial Enzyme Engineering and Enzyme and biosensor Engineering. There are almost 4000+ people from 75 universities in USA working for Enzyme Engineering.

Genetic engineering, additionally called genetic adjustment, is the immediate control of a living being's genome utilizing biotechnology. It is an arrangement of innovations used to change the genetic makeup of cells, including the exchange of genes within and across species boundaries to produce improved or novel organisms. Genetic adjustment, Genome investigation, Genetic designing strategies, Molecular docking and computational transformative science are the diverse points secured under Genetic Engineering.

Proteomics is an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. Protein mass spectrometry refers to the application of mass spectrometry to the study of proteins. Mass spectrometry is an important emerging method for the characterization of proteins. Two-dimensional gel electrophoresis can be used to create cellular protein maps which give a quantitative and qualitative picture of the proteome. Mass spectrometry is the method of choice for the rapid large-scale identification of these proteomes and their modifications. Proteogenomics uses mass spectrometry data to experimentally validate gene products and to assist in the process of genome annotation and comparison. There are almost 3000 people from 60-65 universities in USA working for Proteomics. Research Awards in the amount of $35,000 each are presented annually. Two awards are fully sponsored by Thermo Scientific and Waters Corporation.

There are lot of applications used for protein but mainly we are having good research and number of companies and projects for the following applications Protein modification, targeting and degradation, Protein identification and validation, Protein profiling studies in diabetes, Imaging mass spectrometry and profiling of tissue sections, Designer proteins and Protein Dietary Supplements. This market is $56 billion in 2012 to $168 billion in 2017, a compound annual growth rate (CAGR) of 10.9% from 2012 through 2017. There are almost 3000 people from 60-65 universities in USA working for Genetic and Protein Engineering.

Pharmacogenomics & Pharmacoproteomics is the study of the role of genetics in drug response and provided DNA for genomes. It deals with the influence of acquired and inherited genetic variation on drug response in patients by Protein aggregation and stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficacy and Membrane transport proteins. There are almost 3000 people from 60-65 universities in USA working for Proteomics. The NIH Pharmacogenomics Research Network (PGRN) is a network of scientists funding to PharmGKB since 2000.

The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signaling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. Biomedical Engineering research is the leading research which includes Nano applications to biomedical sciences and tissue engineering, Nano medicines, Cell interactions with nano particles, Revolutionary opportunities and future scope of nanotechnology, Bio-nanotechnology Biomedical Nanotechnology, Tissue Growing Nanostructures, Nano-Mechanisms for Molecular Systems, Nano-Bio-Computing, Biomedical Application of Nanoparticles and Functional Nanomaterials and Devices for Biomedical Engineering.

Protein Engineering is the procedure of creating helpful or profitable proteins and it research happens into the comprehension of collapsing and acknowledgment for protein plan standards. Analysts will have more point by point learning on In vitro development of proteins, Aspects of Biocatalysis, Advances in designing proteins for biocatalysis, Protein Engineered Biomaterials and numerous subjects. Computational Protein Engineering, Constructing practical biocatalysts and Growth of manufactured science are likewise normally utilized themes as a part of protein designing. Protein Engineering business sector is evaluated to develop at a CAGR of 15.7% to reach $1,463.0 million by 2020. There are very nearly 3000 individuals from 60-65 colleges in USA working for Protein Engineering and there are a few meetings and workshops like biomolecular designing gatherings, sub-atomic cell science workshops, protein engineering meetings, antibody engineering 2015 are are conducting throughout the year globally.

Recombinant protein production and purification, Protein expression and purification, CHI protein and Protein electrophoresis are the  topics covered in the protein purification. Protein purification is a series of processes intended to isolate one or a few proteins from a complex mixture, usually cells, tissues or whole organisms. Protein purification is vital for the characterization of the function, structure and interactions of the protein of interest.

Protein Biomarkers, Recombinant protein drugs, Protein gold standards, Protein expression services and market analysis, Fusion protein therapeutics are the various applications and sources for Protein Therapeutics & Market Analysis.Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy.

Protein Expression consists of the stages after DNA has been transcribed to messenger RNA (mRNA) from the process of Optimizing protein expression, Prokaryotic and Eukaryotic systems, Cell line & cell culture development, Fusion protein therapeutics and Protein microarray studies. Recombinant production of proteins is one of the most powerful techniques used in the Life Sciences. There are almost 3000 people from 60-65 universities in USA working for Protein Expression. The Oxford Protein Production Facility-UK (OPPF-UK) is a UK core facility for protein production located in the Research Complex at Harwell. The project has recently received further funding of £2.3M from the MRC to provide a range of highly specialized technologies incorporating robotic systems, for the high throughput expression, purification and crystallization of recombinant proteins.

Proteins are the most versatile macromolecules in living systems and serve crucial functions in essentially all biological processes. The structure and function of proteins includes Function prediction methods, Homology and Structure based methods, Genomic context-based methods, Protein Storage and Plasmid Construction, Mutagenesis Experiments to test protein stability/function and Protein structure modeling. This market is $56 billion in 2012 to $168 billions in 2017, a compound annual growth rate (CAGR) of 10.9% from 2012 through 2017

Transcriptome analysis and Gene Expression is the first and the essential most topics to be discussed. While going in depth of the subject, it is necessary to understand Transcriptome as Key Players in Gene Expression. For that we should know the basics knowledge of how the central dogma works. This can be achieved by gaining proper knowledge about functioning of mRNA, tRNA and rRNA. Gene expression analysis experiments can focus on a subset of relevant target genes. The location of gene and relative distances between genes on a chromosome can be determined through Sequence mapping. Even in the absence of the reference genome, transcriptome can be created using de novo transcriptome assembly method. Globally around thousands of Universities and institutes are carrying research on gene expression and transcriptome analysis.

Molecular modelling is a technique for deriving, representing and manipulating the structures and reactions of molecules, and those properties that are dependent on these three dimensional structure, Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target